Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism

American Journal of Psychiatry

Volumn 157, Issue 1, 2000, Pages 75-80

  Volkow, Nora D ^a   Logan, Jean ^b   Fowler, Joanna S ^b   Wang, Gene Jack ^b   Gur, Ruben C ^b   Wong, Christopher ^b   Felder, Christoph ^b   Gatley, S John ^b   Ding, Yu Shin ^b   Hitzemann, Robert ^b   Pappas, Naomi ^b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; FLUORODEOXYGLUCOSE; GLUCOSE; RACLOPRIDE;

ADULT; AGE; AGED; ARTICLE; BRAIN METABOLISM; CAUDATE NUCLEUS; CINGULATE GYRUS; DOPAMINERGIC SYSTEM; FEMALE; FRONTAL CORTEX; GLUCOSE METABOLISM; HUMAN; MALE; NEUROTRANSMISSION; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL CORTEX;

EID: 16744368750     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.157.1.75     Document Type: Article

References (28)

1. Schneider EL: Aging in the third millennium. Science 1999; 283:796-797
2. Phillips P: European neurologists focus on aging. JAMA 1998; 280:1973-1974
3. Joseph JA, Roth GS, Strong R: The striatum, a microcosm for the examination of age-related alterations in the CNS: a selected review. Rev Biol Res Aging 1990; 4:181-199
4. Volkow ND, Wang G-J, Fowler JS, Logan J, Gatley SJ, MacGregor RR, Schlyer D, Hitzemann R, Wolf AP: Measuring age-related changes in DA D2 receptors with [11C]raclopride and with [18F]N-methylspiroperidol. Psychiatry Res 1996; 67: 11-16
5. Suhara T, Fukuda H, Inoue O, Itoh T, Suzuki K, Yamasaki T, Tateno Y: Age-related changes in human D1 dopamine receptors measured by positron emission tomography. Psychopharmacology (Berl) 1991; 103:41-45
6. Volkow ND, Ding Y-S, Fowler JS, Wang G-J, Logan J, Gatley SJ, Hitzemann R, Smith G, Fields F, Gur R, Wolf AP: Dopamine transporters decrease with age in healthy subjects. J Nucl Med 1996; 37:554-558
7. Eidelberg D, Takikawa S, Dhawan V, Chaly T, Robeson W, Dahl R, Margouleff D, Moeller JR, Patlak CS, Fahn S: Striatal 18F-DOPA uptake: absence of an aging effect. J Cereb Blood Flow Metab 1993; 13:881-888
8. Volkow ND, Fowler JS, Gatley JS, Logan J, Wang G-J, Ding YS, Dewey SL: PET evaluation of the dopamine system of the human brain. J Nucl Med 1996; 37:1242-1256
9. Volkow ND, Gur RC, Wang G-J, Fowler JS, Moberg PJ, Ding Y-S, Hitzemann R, Smith G, Logan J: Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 1998; 155:344-349
10. Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Mandel F, Alexander GE, Grady C, Pietrini P, Eidelberg D: The metabolic topography of normal aging. J Cereb Blood Flow Metab 1996; 16:385-398
11. Heimer L, Alheid GF, Zaborzky L: The basal ganglia, in The Rat Nervous System. Edited by Paxinos G. New York, Academic Press, 1985, pp 37-74
12. Williams SM, Goldman-Rakic PS: Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex 1998; 8: 321-345
13. Daniel DG, Weinberger DR, Jones DW, Zigun JR, Coppola R, Handel S, Bigelow LB, Goldberg TE, Berman KF, Kleinman JE: The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 1991; 11:1907-1917
14. Dolan RJ, Fletcher P, Frith CD, Friston KJ, Frackowiak RSJ, Grasby PM: Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature 1995; 378:180-182
15. Volkow ND, Fowler JS, Wang G-J, Dewey SL, Schlyer D, MacGregor R, Logan J, Alexoff D, Shea C, Hitzemann R, Angrist B, Wolf AP: Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. J Nucl Med 1993; 34:609-613
16. Wang G-J, Volkow ND, Roque CT, Cestaro VL, Hitzemann RJ, Cantos EL, Levy AV, Dhawan AP: Functional importance of ventricular enlargement and cortical atrophy in healthy subjects and alcoholics as assessed with PET, MR imaging, and neuropsychologic testing. Radiology 1992; 186:59-65
17. Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer D, MacGregor RR, Hitzemann R, Bendriem B, Gatley SJ, Christman DR: Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1990; 10:740-747
18. Logan J, Volkow ND, Fowler JS, Wang G-J, Dewey SL, MacGregor R, Schlyer D, Gatley SJ, Pappas N, King P, Hitzemman R, Vitkun S: Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 1994; 14:995-1010
19. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. New York, Thieme Medical, 1988
20. SPM95 Software. London, Hammersmith Hospital, MRC Cyclotron Unit, 1995
21. Flannery BP, Teukplsky SA, Vetterling WT: Numerical Recipes In C: The Art of Scientific Computing. Cambridge, UK, Cambridge University Press, 1988
22. Volkow ND, Fowler JS, Wang G-J, Hitzemann R, Logan J, Schlyer D, Dewey S, Wolf AP: Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993; 14:169-177
23. West RL: An application of prefrontal cortex function theory to cognitive aging. Psychol Bull 1996; 120:272-292
24. Weinberger DR, Berman KF, Zee RF: Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow evidence. Arch Gen Psychiatry 1986; 43: 114-124
25. Pardo JV, Pardo PJ, Janer KW, Raichle ME: The anterior cingulate cortex mediates processing selection in the Stroop Attentional Conflict Paradigm. Proc Natl Acad Sci USA 1990; 87:256-259
26. Grace AA: Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 1991; 41:1-24
27. Volkow ND, Wang G-J, Fowler JS, Logan J, Angrist B, Hitzemann R, Lieberman J, Pappas N: Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry 1997; 154:50-55
28. Schlageter NL, Horwitz B, Creasey H, Carson R, Duara R, Berg GW, Rapoport SI: Relation of measured brain glucose utilisation and cerebral atrophy in man. J Neurol Neurosurg Psychiatry 1987; 50:779-785